Zoetis Inc.

ZTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $5.83B $5.31B $4.89B $4.77B $4.79B $4.56B $4.34B $4.23B
Cost of Revenue $1.91B $1.78B $1.67B $1.74B $1.72B $1.67B $1.56B $1.65B
Gross Profit $3.91B $3.53B $3.22B $3.03B $3.07B $2.89B $2.77B $2.58B
Gross Margin 67.2% 66.6% 65.9% 63.5% 64.1% 63.4% 64.0% 61.0%
Operating Expenses
Research & Development
SG&A Expense $1.48B $1.33B $1.36B $1.53B $1.64B $1.61B $1.47B $1.45B
Operating Income $1.90B $1.70B $1.39B $669.0M $937.0M $803.0M $741.0M $430.0M
Operating Margin 32.5% 32.0% 28.5% 14.0% 19.6% 17.6% 17.1% 10.2%
Interest Expense $206.0M $175.0M $166.0M $124.0M $117.0M $113.0M $31.0M $36.0M
Pretax Income $1.69B $1.53B $1.23B $545.0M $820.0M $690.0M $710.0M $394.0M
Income Tax Expense $266.0M $663.0M $409.0M $206.0M $233.0M $187.0M $274.0M $146.0M
Net Income $1.43B $864.0M $821.0M $339.0M $583.0M $504.0M $436.0M $245.0M
Net Margin 24.5% 16.3% 16.8% 7.1% 12.2% 11.1% 10.1% 5.8%
EPS (Basic) $2.96 $1.76 $1.66 $0.68 $1.16 $1.01 $0.87 $0.49
EPS (Diluted) $2.93 $1.75 $1.65 $0.68 $1.16 $1.01 $0.87 $0.49
Shares Outstanding (Basic) 483.1M 489.9M 495.7M 499.7M 501.1M 500.0M 500.0M 500.0M
Shares Outstanding (Diluted) 486.9M 493.2M 498.2M 502.0M 502.0M 500.3M 500.0M 500.0M
Dividends Per Share $0.54 $0.44 $0.39 $0.34 $0.30 $0.27 $0.00 $0.00
← Newer Page 2 of 2 Older →